Fariba Navid

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma”.

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709

N/A

0.652DataRank · unranked

20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000590

N/A

0.340DataRank · unranked

5 citations

Fariba Navid, Jacquelyn A. Hank, Amy K. Erbe, Victor M. Santana, Jacek Gan +12 more

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561

N/A

0DataRank · unranked

4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group

European Journal of Cancer(2025)10.1016/j.ejca.2025.115600

N/A

0DataRank · unranked

1 citations

David P. Douglass, Sapna Oberoi, Natalie B. Collins, Ajay Gupta, Jonathan Metts +17 more